Erectile dysfunction profoundly impacts the quality of life of 10 to 30 million American men. The NIH Consensus Development Conference on Impotence (December, 1992) considered erectile dysfunction as an important public health problem and pointed to the need for basic research on the biochemical and physiological mechanisms that underlie etiology, pathogenesis and response to treatment of erectile dysfunction. Over the past ten years, considerable progress has been made towards understanding the epidemiological, neuropharmacological and therapeutic aspects of erectile dysfunction. Although pharmacologic intervention via self- intracavernosal injection of vasoactive agents restores erectile function in many patients, this therapeutic approach remains widely unaccepted. The desire and expectation by patients to seek pharmacological (non-invasive) treatment, especially oral medications, requires the development of innovative approaches and strategies that enable effective manipulations of trabecular smooth muscle tone by oral medications. To achieve this goal, a more detailed understanding of penile smooth muscle neuromodulation at the biochemical and molecular levels is necessary. The studies proposed here will focus on the biochemical mechanisms and functional role of a1-adrenergic and muscarinic receptor subtypes in the local control of trabecular smooth muscle tone.
The specific aims are: 1) to determine the functional role of a1-adrenergic receptor subtypes (a1-AR) in modulating corpus cavernosum smooth muscle tone; 2) to determine the functional role of muscarinic acetylcholine receptor (mAChR) subtypes in regulation of corpus cavernosum smooth muscle tone; and 3) to determine the regulation of expression of mAChR and a1A, a1B and A1C-AR subtypes in corpus cavernosum smooth muscle by androgens, neurotransmitters, and vasoactive agents. The long term objective is to delineate the biochemical basis of neurotransmitter-receptor function and the interplay (regulation) between adrenergic, cholinergic and non-adrenergic noncholinergic signals in modulating trabecular smooth muscle tone.
|Moreland, R B; Kim, N; Nehra, A et al. (2003) Functional prostaglandin E (EP) receptors in human penile corpus cavernosum. Int J Impot Res 15:362-8|
|Moreland, R B; Nehra, A; Kim, N N et al. (2002) Expression of functional prostaglandin D (DP) receptors in human corpus cavernosum smooth muscle. Int J Impot Res 14:446-52|
|Moreland, R B; Albadawi, H; Bratton, C et al. (2001) O2-dependent prostanoid synthesis activates functional PGE receptors on corpus cavernosum smooth muscle. Am J Physiol Heart Circ Physiol 281:H552-8|
|Udelson, D; L'Esperance, J; Morales, A M et al. (2000) The mechanics of corporal veno-occlusion in penile erection: a theory on the effect of stretch-associated luminal constrictability on outflow resistance. Int J Impot Res 12:315-27|
|Kim, N N; Goldstein, I; Moreland, R B et al. (2000) Alpha-adrenergic receptor blockade by phentolamine increases the efficacy of vasodilators in penile corpus cavernosum. Int J Impot Res 12 Suppl 1:S26-36|
|Traish, A; Kim, N N; Moreland, R B et al. (2000) Role of alpha adrenergic receptors in erectile function. Int J Impot Res 12 Suppl 1:S48-63|
|Moreland, R B; Kim, N N; Nehra, A et al. (2000) Misoprostol induces relaxation of human corpus cavernosum smooth muscle: comparison to prostaglandin E1. Int J Impot Res 12:107-10|
|Traish, A; Kim, N N; Huang, Y H et al. (2000) Cyclic AMP regulates mRNA expression of alpha-1d and alpha-2a adrenergic receptors in cultured human corpus cavernosum smooth muscle cells. Int J Impot Res 12 Suppl 1:S41-47|
|Traish, A M; Kim, N N; Goldstein, I et al. (1999) Alpha-adrenergic receptors in the penis: identification, characterization, and physiological function. J Androl 20:671-82|
|Traish, A M; Park, K; Dhir, V et al. (1999) Effects of castration and androgen replacement on erectile function in a rabbit model. Endocrinology 140:1861-8|
Showing the most recent 10 out of 59 publications